Frequency and Severity of Adverse Drug Events by Medication Classes: The JADE Study

被引:6
作者
Sakuma, Mio [1 ,2 ]
Kanemoto, Yuko [2 ]
Furuse, Akari [2 ]
Bates, David W. [3 ,4 ,5 ]
Morimoto, Takeshi [1 ]
机构
[1] Hyogo Coll Med, Dept Clin Epidemiol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, Dept English, Fac Med, Nishinomiya, Hyogo, Japan
[3] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
[5] Harvard Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
关键词
adverse drug events; epidemiology; patient safety; risk; POSTMARKETING SURVEILLANCE; HOSPITALIZED-PATIENTS;
D O I
10.1097/PTS.0000000000000235
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective Adverse drug events (ADEs) are a significant concern in daily practice; however, the profile of high-risk drugs remains unclear. Our objective was to categorize high-risk medication classes according to frequency and severity of ADEs. Methods The JADE study is a prospective cohort study of 3459 hospitalized adult patients. We investigated the ADEs and medications prescribed to the patients. The rate of ADEs for each medication class was calculated by dividing the number of ADEs by the number of patients who received each medication class on admission. Results Overall, 14,435 medications were ordered on admission for patients (median 4; interquartile range, 2-6). Electrolytes and fluids were most frequently prescribed (1876 patients, 54%). Sedatives, antibiotics, peptic ulcer drugs, and analgesics were also commonly prescribed. The frequency was similar in both elderly and younger patients. Among 1010 identified ADEs, antibiotics were most frequently associated with ADEs (31 ADEs per 100 prescribed patients on admission). In patients 65 years and older, corticosteroids, anticonvulsants, laxatives, nonsteroidal anti-inflammatory drugs, and antipsychotics were the 5 most frequent medication classes causing ADEs following antibiotics. In patients younger than 65 years, antibiotics were also the most frequent cause of ADEs, followed by laxatives, lipid-lowering agents, anticonvulsants, and corticosteroids. Among cardiovascular agent-associated ADEs, 46% were fatal or life threatening in elderly patients, whereas antihypertensives were most often associated with fatal or life-threatening ADEs (25%) in younger patients. Conclusions The medication classes frequently associated with ADEs did not necessarily induce severe ADEs.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 13 条
[1]   Adverse drug event monitoring at the Food and Drug Administration - Your report can make a difference [J].
Ahmad, SR .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (01) :57-60
[2]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[3]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[4]   Postmarketing surveillance and adverse drug reactions - Current perspectives and future needs [J].
Brewer, T ;
Colditz, GA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (09) :824-829
[5]   Medication use leading to emergency department visits for adverse drug events in older adults [J].
Budnitz, Daniel S. ;
Shehab, Nadine ;
Kegler, Scott R. ;
Richards, Chesley L. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (11) :755-U26
[6]   Postmarketing surveillance - Lack of vigilance, lack of trust [J].
Fontanarosa, PB ;
Rennie, D ;
DeAngelis, CD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2647-2650
[7]  
Institute for Safe Medication Practices, ISMPS LIST HIGH AL M
[8]   Improving detection of adverse effects of marketed drugs [J].
Klein, Donald F. ;
O'Brien, Charles P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03) :333-334
[9]   THE NATURE OF ADVERSE EVENTS IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-II [J].
LEAPE, LL ;
BRENNAN, TA ;
LAIRD, N ;
LAWTHERS, AG ;
LOCALIO, AR ;
BARNES, BA ;
HEBERT, L ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :377-384
[10]  
Lucado J., 2011, Report No.: HCUP Statistical Brief #109.